Dr. Parminder Singh Dhingra, MD

Dr. Dhingra practices at Davie Surgery - Ophthalmology - HOPD in Bermuda Run, North Carolina.

Dr. Dhingra's NPI, 1457882599, was assigned on March 21, 2017. Dr. Dhingra holds Pennsylvania license MD476367.

Dr. Dhingra's primary practice is Davie Surgery - Ophthalmology - HOPD, at 329 Nc Highway 801 N, Bermuda Run, NC 27006.

Dr. Dhingra's primary practice is Davie Surgery - Ophthalmology - HOPD in Bermuda Run, North Carolina. Dr. Dhingra is also affiliated with Atrium Health Wake Forest Baptist Medical Center. The medical group on file is Atrium Health Wake Forest Baptist. Dmand AI also links Dr. Dhingra to 2 more hospitals and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dhingra practices, 4 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Dhingra's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dmand AI has Dr. Dhingra's licenses on file in 3 states: Pennsylvania, Connecticut and Ohio.

CMS data shows 944 Medicare services from Dr. Dhingra across 6 procedure codes in 2024, for 422 Medicare patients. Medicare paid $65,738 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 422 Medicare patients who saw Dr. Dhingra in 2024. The largest group is 75 to 84, with 158 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 2.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dhingra's median patient age at 73, with 58% women.

In 2024, Dr. Dhingra wrote 308 Medicare Part D claims for 123 patients. 79% of them were for generic drugs. CMS names the drug for 91 of them, across 6 drugs with 11 or more claims each, at $9,913 in total drug cost. In 2023, CMS named 78 claims across 5 drugs.

Dr. Dhingra accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Dhingra in 2019. 2019 was the busiest year, with 2. Dr. Dhingra's most frequent co-authors are Tanureet Kochar, MD, Muhammad Farhan Khaliq, MD and Brittain McJunkin, MD.

CMS Open Payments shows 19 general payments to Dr. Dhingra from 11 drug and device companies from 2017 to 2022. Food and beverage make up the largest share, 100% of the total. Bristol-Myers Squibb Company paid the most, $88.